Jane E Henney, MD, becomes the first woman Commissioner of Food and Drugs
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
On Jan. 17, 1999, Jane E. Henney, M.D., appointed by President Bill Clinton, became the first woman to…
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
In 1999, Dr. Emil Kakkis at Los Angeles Biomedical Research Institute (LA BioMed) developed Enzyme Replacement Therapy to…
In 1999, the Del E. Webb Center for Neuroscience and Aging, which focuses on diseases such as stroke,…
In 1999, the Delaware Biotechnology Institute was founded as a partnership among government, academia and industry to help…
In January 1999, the National Birth Defects Prevention Network (NBDPN) established a SurveillanceGuidelines and Standards Committee (SGSC) in…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) launched the National Pharmaceutical Stockpile, now the…
In 1999, The Indiana University (IU) Cancer Center became an National Cancer Institute (NCI)-designated cancer center. Its mission…
In 1999, the U.S. Centers for Disease Control and Prevention (CDC) established the Laboratory Response Network (LRN). The…
In 1999, the Hudson-Webber Cancer Research Center opened to serve as a ‘translational’ research facility, bridging the gaps…
In 1999, the Fred Hutchinson Business Alliance announced that the 1999 E. Donnall Thomas Medal of Achievement would…
In 1999, Timothy J. Eberlein, MD was named director of the Alvin J. Siteman Cancer Center. As director…
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
In 1999, the Eppley Cancer Center became a National Cancer Institute (NCI) designated cancer center. NCI grant funding…
On Jan. 1, 1999, HIV infection in adults (clients 13 years of age or older) became reportable by…
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, ClinicalTrials.gov was founded as an Internet-based resource that provide information about clinical research studies to the…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
In Oct. 1998, the Fetal Alcohol Syndrome Surveillance Network was created to determine the prevalence of FAS within…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…